Trials / Completed
CompletedNCT05167123
Pulp Capping in Primary Molars Using TheraCal (LC)
Radiographic and Clinical Evaluation of Indirect and Direct Pulp Capping in Primary Molars Using TheraCal (LC)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 4 Years – 7 Years
- Healthy volunteers
- Accepted
Summary
A randomized clinical trial that aims to evaluate clinical and radiographic success rates of indirect pulp capping and direct pulp capping in primary molars with reversible pulpitis using a light-cured tri-calcium silicate base material (TheraCal (LC)).
Detailed description
Participating primary molars will be randomly allocated to one of the following groups: Indirect pulp capping group or Direct pulp capping group. A light-cured tri-calcium silicate base material (TheraCal (LC) ) will be used in the two groups as a dressing material. Patients will be recruited from the outpatient clinic of the pediatric dentistry department, Faculty of Dentistry Ain Shams University. The participant will be recalled for follow-up assessments at 3, 6,9, and 12 months.
Conditions
- Deep Caries
- Indirect Pulp Capping
- Direct Pulp Capping
- Reversible Pulpitis
- Decayed Teeth
- Vital Pulp Therapy
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Light cured tri-calcium silicate base material | TheraCal (LC) (BISCO Inc., Schamburg, IL, USA) was introduced in (2011), are available commercially as flowable cement applicable via syringe |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2021-11-30
- Completion
- 2021-12-15
- First posted
- 2021-12-22
- Last updated
- 2023-02-03
Locations
3 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05167123. Inclusion in this directory is not an endorsement.